Clinical and procedural predictors of suboptimal myocardial reperfusion in primary percutaneous coronary intervention
- PMID: 31032395
- PMCID: PMC6477166
- DOI: 10.1016/j.ijcha.2019.100357
Clinical and procedural predictors of suboptimal myocardial reperfusion in primary percutaneous coronary intervention
Abstract
Background: Suboptimal myocardial perfusion in primary PCI is associated with increased infarct size, left ventricular (LV) dysfunction and higher mortality rates as compared as those with optimal myocardial perfusion. We identified clinical and procedural predictors of suboptimal myocardial reperfusion as judged by myocardial plush grade (MBG) in primary PCI.
Methods and results: 100 patients with acute STEMI who underwent primary PCI were prospectively subjected to clinical, ECG, laboratory and angiographic evaluation. Patients were classified into: Optimal myocardial reperfusion group: (n=73) who had final MBG=3. Suboptimal myocardial reperfusion group: (n=27) who had persistent final MBG ≤ 2. Suboptimal myocardial reperfusion group had statistically significant little history of angina prior to MI 5 (18.5%) vs 44 (60.3%), little current aspirin intake 6(22%) vs 38 (52% ), increased blood sugar on admission (240 ± 101 mg/dl vs 171 ± 72 mg/dl), increased total leucocytic count on admission (12.1 ± 3.6 vs 10.2 ± 3.3) 103/mm3, longer reperfusion time (6.1 ± 2.8 vs 4.3 ± 2.1 h ), higher thrombus burden 12 (44.4 % ) vs 13 (17.8 %), higher predilatation pressure (16 ± 2.3 vs 14 ± 1.8 ATM), repeated balloon inflation during predilatation 24 (92.3 % ) vs 46 (69.7%) as compared optimal myocardial reperfusion group, (P < 0.05 for all).
Conclusion: Longer reperfusion time, repeated balloon inflations, high predilatation pressure> 15 ATM , high thrombus burden, neither history of angina nor aspirin intake prior to AMI, high total leucocytic count > 10103/mm3 and high blood glucose level > 160mg/dl were predictors for persistent suboptimal myocardial reperfusion in primary PCI.
Keywords: Myocardial perfusion; Predictors; Primary PCI.
Similar articles
-
Predictors of no-reflow phenomenon following percutaneous coronary intervention for ST-segment elevation myocardial infarction.Ann Cardiol Angeiol (Paris). 2021 Jun;70(3):136-142. doi: 10.1016/j.ancard.2021.04.004. Epub 2021 May 4. Ann Cardiol Angeiol (Paris). 2021. PMID: 33962782
-
Effect of Hematologic Parameters on Microvascular Reperfusion in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.Angiology. 2016 Feb;67(2):151-6. doi: 10.1177/0003319715583204. Epub 2015 May 25. Angiology. 2016. PMID: 26007233
-
Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial.J Am Coll Cardiol. 2005 Jul 19;46(2):371-6. doi: 10.1016/j.jacc.2005.04.057. J Am Coll Cardiol. 2005. PMID: 16022970 Clinical Trial.
-
Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention.World J Emerg Med. 2014;5(2):96-102. doi: 10.5847/wjem.j.issn.1920-8642.2014.02.003. World J Emerg Med. 2014. PMID: 25215156 Free PMC article.
-
Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.JACC Cardiovasc Interv. 2013 Jul;6(7):718-24. doi: 10.1016/j.jcin.2013.03.013. JACC Cardiovasc Interv. 2013. PMID: 23866184 Clinical Trial.
Cited by
-
A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon.Diagnostics (Basel). 2022 Apr 8;12(4):932. doi: 10.3390/diagnostics12040932. Diagnostics (Basel). 2022. PMID: 35453980 Free PMC article. Review.
-
No-reflow phenomenon in acute myocardial infarction: Relieve pressure from the procedure and focus attention to the patient.Int J Cardiol Heart Vasc. 2019 Aug 30;24:100417. doi: 10.1016/j.ijcha.2019.100417. eCollection 2019 Sep. Int J Cardiol Heart Vasc. 2019. PMID: 31508482 Free PMC article. No abstract available.
-
The role and mechanisms of microvascular damage in the ischemic myocardium.Cell Mol Life Sci. 2023 Oct 29;80(11):341. doi: 10.1007/s00018-023-04998-z. Cell Mol Life Sci. 2023. PMID: 37898977 Free PMC article. Review.
-
Clinical, Laboratory, and Procedural Predictors of No-Reflow in Patients Undergoing Primary Percutaneous Coronary Intervention.J Tehran Heart Cent. 2020 Apr;15(2):50-56. doi: 10.18502/jthc.v15i2.4183. J Tehran Heart Cent. 2020. PMID: 33552194 Free PMC article.
References
-
- Giampaolo N., Rajesh K.K., Filippo C., Adrian P.B. No-reflow: again prevention is better than treatment. Eur. Heart J. 2010;31:2449–2455. - PubMed
-
- Schröder R., Dissmann R., Brüggemann T., Wegscheider K., Linderer T., Tebbe U., Neuhaus K.L. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 1994 Aug;24(2):384–391. - PubMed
-
- Gibson C.M., de Lemos J.A., Murphy S.A. Combination therapy with Abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001;103:2550–2554. - PubMed
-
- Arnoud W.J. van `t Hof, Aylee Liem, Harry Suryapranata, Jan C.A. Hoorntje, Menko-Jan de, Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction myocardial blush grade. Circulation. 1998;97:2302–2306. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous